Literature DB >> 23820752

Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicopathological and molecular features.

Alessandra Capodanno1, Laura Boldrini, Agnese Proietti, Greta Alì, Serena Pelliccioni, Cristina Niccoli, Armida D'Incecco, Federico Cappuzzo, Antonio Chella, Marco Lucchi, Alfredo Mussi, Gabriella Fontanini.   

Abstract

MicroRNAs (miRNAs) play a key role in cancer pathogenesis and are involved in several human cancers, including non-small cell lung cancer (NSCLC). This study evaluated Let-7g and miR-21 expression by quantitative real-time PCR in 80 NSCLC patients and correlated the results with their main clinicopathological and molecular features. MiR-21 expression was significantly higher in NSCLC tissues compared to non-cancer lung tissues (p<0.0001), while no significant changes in Let-7g expression were observed between the tumor and normal lung tissues. Target prediction analysis led to the identification of 26 miR-21 and 24 Let-7g putative target genes that play important roles in cancer pathogenesis and progression. No significant association was observed between the analysed miRNAs and the main clinicopathological or molecular characteristics of the NSCLC patients, although both miRNAs were downregulated in squamous cell carcinomas compared to adenocarcinomas. Noteworthy, we observed a significant association between low Let-7g expression and metastatic lymph nodes at diagnosis (p=0.046), as well as between high miR-21 expression and K-Ras mutations (p=0.0003). Survival analysis did not show any significant correlation between prognosis and the analysed miRNAs, although the patients with a high Let-7g and miR-21 expression showed a significantly lower short-term progression-free survival (p=0.01 and p=0.0003, respectively) and overall survival (p=0.023 and p=0.0045, respectively). In conclusion, we showed that Let-7g and miR-21 expression was deregulated in NSCLC and we demonstrated a strong relationship between miR-21 overexpression and K-Ras mutations. Our data indicate that Let-7g and miR-21 profiling combined with the determination of K-Ras mutational status may be considered a useful biomarker for a more effective molecular characterization and clinical management of NSCLC patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23820752     DOI: 10.3892/ijo.2013.2003

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  35 in total

1.  MicroRNA-10a-5p and microRNA-34c-5p in laryngeal epithelial premalignant lesions: differential expression and clinicopathological correlation.

Authors:  Yanping Hu; Honggang Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-09-30       Impact factor: 2.503

2.  Genistein inhibits A549 human lung cancer cell proliferation via miR-27a and MET signaling.

Authors:  Yang Yang; Aimin Zang; Youchao Jia; Yanhong Shang; Zhuoqi Zhang; Kun Ge; Jinchao Zhang; Wufang Fan; Bei Wang
Journal:  Oncol Lett       Date:  2016-07-06       Impact factor: 2.967

3.  Exosome-mediated gefitinib resistance in lung cancer HCC827 cells via delivery of miR-21.

Authors:  Changwen Jing; Haixia Cao; Xiaobing Qin; Shaorong Yu; Jianzhong Wu; Zhuo Wang; Rong Ma; Jifeng Feng
Journal:  Oncol Lett       Date:  2018-04-27       Impact factor: 2.967

Review 4.  MicroRNAs in lung cancer.

Authors:  Pooja Joshi; Justin Middleton; Young-Jun Jeon; Michela Garofalo
Journal:  World J Methodol       Date:  2014-06-26

5.  Serum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screening.

Authors:  Jin-shan Yang; Bao-jian Li; Hua-wei Lu; Yu Chen; Chuan Lu; Rui-xia Zhu; Si-hai Liu; Qing-ting Yi; Jing Li; Chun-hui Song
Journal:  Tumour Biol       Date:  2014-12-14

Review 6.  Overview upon miR-21 in lung cancer: focus on NSCLC.

Authors:  Cecilia Bica-Pop; Roxana Cojocneanu-Petric; Lorand Magdo; Lajos Raduly; Diana Gulei; Ioana Berindan-Neagoe
Journal:  Cell Mol Life Sci       Date:  2018-07-20       Impact factor: 9.261

Review 7.  MicroRNA as tools and therapeutics in lung cancer.

Authors:  Jennifer F Barger; S Patrick Nana-Sinkam
Journal:  Respir Med       Date:  2015-02-19       Impact factor: 3.415

8.  Diagnostic value of microRNA-21 in the diagnosis of lung cancer: evidence from a meta-analysis involving 11 studies.

Authors:  Renjie Wu; Yingjiu Jiang; Qingcheng Wu; Qiang Li; Dan Cheng; Ling Xu; Cheng Zhang; Ming Zhang; Ling Ye
Journal:  Tumour Biol       Date:  2014-06-01

9.  The role of plasma miRNAs in the diagnosis of pulmonary nodules.

Authors:  Ke-Xing Xi; Xue-Wen Zhang; Xiang-Yang Yu; Wei-Dong Wang; Ke-Xiang Xi; Yong-Qiang Chen; Ying-Sheng Wen; Lan-Jun Zhang
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

10.  Analysis for the mechanism between the small cell lung cancer and non-small cell lung cancer combing the miRNA and mRNA expression profiles.

Authors:  Weisan Zhang; Qiang Zhang; Mingpeng Zhang; Yun Zhang; Fengtan Li; Ping Lei
Journal:  Thorac Cancer       Date:  2015-01-07       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.